Get the Stockscreener App
0.659
0.05%
-0.0085
After Hours:
.65
-0.009
-1.37%
Bluejay Diagnostics Inc stock is traded at $0.659, with a volume of 81,993.
It is down -0.05% in the last 24 hours and down -46.70% over the past month.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.
See More
Previous Close:
$0.6505
Open:
$0.65
24h Volume:
81,993
Relative Volume:
0.03
Market Cap:
$1.20M
Revenue:
-
Net Income/Loss:
$-8.59M
P/E Ratio:
-0.00048
EPS:
-1373
Net Cash Flow:
$-9.25M
1W Performance:
-2.55%
1M Performance:
-46.70%
6M Performance:
-60.11%
1Y Performance:
-83.11%
1-Day Range:
$0.6333
$0.69
1-Week Range:
$0.6273
$0.70
52-Week Range:
$0.6273
$10.20
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Name
Bluejay Diagnostics Inc
Sector
Industry
Phone
(978) 631-0152
Address
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
0.659 | 1.18M | 0 | -8.59M | -9.25M | -1,373.00 |
|
ABT
Abbott Laboratories
|
127.03 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.67 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.58 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.76 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.85 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bluejay Diagnostics Inc Stock (BJDX) Latest News
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Bluejay Diagnostics Inc. (BJDX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What analysts say about Bluejay Diagnostics Inc stockPortfolio Diversification Tips & Outstanding Growth Stocks - earlytimes.in
Why Bluejay Diagnostics Inc. stock could see breakout soonRSI Overbought/Oversold & Big Profit Small Budget - bollywoodhelpline.com
Bluejay Diagnostics Completes Commercial-Scale IL-6 Antibody Production - TradingView — Track All Markets
Working capital per share of Bluejay Diagnostics, Inc. – NASDAQ:BJDX - TradingView — Track All Markets
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Significant Increase in Short Interest - Defense World
Bluejay Diagnostics completes antibody production for IL-6 test system By Investing.com - Investing.com Nigeria
Bluejay Diagnostics announces completion of commercial-scale IL-6 antibody production - marketscreener.com
Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production - TradingView — Track All Markets
Bluejay Diagnostics completes antibody production for IL-6 test system - Investing.com
Bluejay Diagnostics, Inc. Completes Commercial-Scale Production of IL-6 Antibodies for Symphony™ System - Quiver Quantitative
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Enough IL-6 test antibodies made to power 9M diagnostic cartridges - Stock Titan
Bluejay Diagnostics Stock Plummets 37% With 11-Day Losing Streak - Trefis
10-Day Sell-Off Sends Bluejay Diagnostics Stock Down 34% - Trefis
Is Bluejay Diagnostics Inc. stock a defensive play in 2025Market Trend Summary & Verified Technical Signals - Улправда
Can Bluejay Diagnostics Inc. stock hit record highs againWeekly Market Report & Entry Point Strategy Guides - Улправда
Analyst Calls: Is Bluejay Diagnostics Inc. stock attractive for passive investorsEarnings Miss & Free Real-Time Market Sentiment Alerts - Улправда
What makes Bluejay Diagnostics Inc. stock attractive to growth fundsWeekly Market Outlook & Free Safe Capital Growth Stock Tips - DonanımHaber
Why Bluejay Diagnostics Inc. stock remains a top recommendation2025 Institutional Moves & Technical Buy Zone Confirmation - DonanımHaber
Bluejay Diagnostics Earnings Notes - Trefis
This trade activity should not be overlooked: Bluejay Diagnostics Inc (BJDX) - Setenews
Can Bluejay Diagnostics Inc. stock sustain institutional interestJuly 2025 Reactions & Short-Term High Return Strategies - Newser
Bluejay Diagnostics (BJDX) Stock Analysis Report | Financials & Insights - Benzinga
Bluejay Diagnostics (NASDAQ:BJDX) Shares Down 6.2% – Time to Sell? - Defense World
Bluejay Diagnostics Inc Stock Analysis and ForecastFlag and Pennant Patterns & Exceptional Capital Investment - earlytimes.in
Why Bluejay Diagnostics Inc. stock could outperform in 20252025 Volatility Report & Low Drawdown Trading Techniques - newser.com
How Bluejay Diagnostics Inc. stock reacts to oil pricesQuarterly Profit Report & High Conviction Buy Zone Alerts - newser.com
Why Bluejay Diagnostics Inc. stock could benefit from AI revolution2025 Price Targets & Low Risk Entry Point Tips - newser.com
How geopolitical tensions affect Bluejay Diagnostics Inc. stockJuly 2025 Macro Moves & Low Risk Entry Point Guides - newser.com
Statistical indicators supporting Bluejay Diagnostics Inc.’s strengthEarnings Beat & High Conviction Buy Zone Picks - newser.com
Bluejay Diagnostics Inc Stock (BJDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):